Studio discussion: bronchiectasis, cystic fibrosis, tuberculosis and lung cancer

Asthma and COPD may be the ‘bread and butter’ of the respiratory conditions seen in primary care, but other respiratory conditions, such as bronchiectasis, will also be seen. In this episode of the MIMS Learning Clinical Update podcast, MIMS Learning editors Dawn and Pat survey the wide range of respiratory conditions seen in primary care that are not COPD or asthma. They look at the diagnosis of bronchiectasis, improvements in managing cystic fibrosis, the rising incidence of tuberculosis (TB), and how the NHS Lung Cancer Screening Programme is enabling earlier diagnosis.Educational objectivesAfter listening to this podcast, healthcare professionals should be better able to: Describe the pathophysiology of bronchiectasisReview how developments in screening and management has improved outcomes in cystic fibrosisDiscuss which socioeconomic groups are at increased risk of tuberculosisRecall the number of lung cancers detected through the NHS lung cancer screening programmeYou can access the website version of this podcast, along with a list of key learning points, on MIMS Learning - and make notes for your appraisal. MIMS Learning offers hundreds of hours of CPD for healthcare professionals, along with a handy CPD organiser.Please note: this podcast is presented by medical editors and discusses educational content written or presented by doctors, nurses and other healthcare professionals on the MIMS Learning website and at live events.MIMS LearningSubscribe to MIMS LearningBronchiectasis: clinical reviewCystic fibrosis: clinical reviewInflammatory bowel disease mimicsLung cancer: presentation and referralPodcast: advanced nurse practitioner Beverley Bostock on asthma and COPDPodcast bonus episode: Dr Steve Holmes on asthma in pregnancy and childhood wheezeMIMSEarly start to flu season prompts warning for healthcare professionalsInfluenza vaccines 2025/2026Influenza vaccines, which vaccine to offer Hosted on Acast. See acast.com/privacy for more information.

There are no comments yet.

Please log in to write the first comment.